Neurokinin-1 receptor antagonist aprepitant regulates autophagy and apoptosis through ROS/JNK pathway in intrahepatic cholangiocarcinoma
Authors:
Preprint
- 2 March 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Intrahepatic cholangiocarcinoma (iCCA) has a poor prognosis and limited treatment options. Aprepitant, a selective NK-1R antagonist, is capable of inhibiting the growth of various tumors in vitro and in vivo. To investigate the cytotoxic effects of aprepitant on the intrahepatic cholangiocarcinoma, we confirmed the expression of SP/NK-1R in clinical samples of iCCA by immunohistochemistry. MTT test showed that aprepitant could suppress cell viability of RBE and HCCC-9810. Meanwhile, aprepitant induced mitochondria-dependent apoptosis through ROS/JNK pathway in a dose-dependent manner. Additionally, anti-apoptotic drug z-VAD-fmk pretreatment could partly improve the decrease of cell viability induced by aprepitant, while ROS scavenger, NAC could cancel the cytotoxic effects of aprepitant in vitro. Therefore, these results indicated that autophagy is another downstream process of aprepitant-induced ROS accumulation. Changes in the expression of autophagy-related proteins and number of autophagosomes were detected by western blotting and electron microscopy, respectively. Furthermore, we observed the dynamic changes of autophagosome in RBE and HCCC-9810 treated with aprepitant by using mRFP-eGFP-LC3 adenovirus transfection. Moreover, aprepitant significantly inhibited the growth of iCCA xenografts. These findings reveal NK-1R as an potential therapeutic target against iCCA and highlight the anti-cancer ability of NK-1R antagonist aprepitant in iCCA.Keywords
All Related Versions
This publication has 24 references indexed in Scilit:
- TGFβ regulates NK1R-Tr to affect the proliferation and apoptosis of breast cancer cellsLife Sciences, 2020
- The emerging role of substance P/neurokinin-1 receptor signaling pathways in growth and development of tumor cellsJournal of Physiology and Biochemistry, 2019
- JNK signaling in cancer cell survivalMedicinal Research Reviews, 2019
- Substance P and pain chronicityCell and tissue research, 2018
- Truncation of neurokinin-1 receptor—Negative regulation of substance P signalingJournal of Leukocyte Biology, 2018
- Cholangiocarcinoma — evolving concepts and therapeutic strategiesNature Reviews Clinical Oncology, 2017
- Antitumor action of temozolomide, ritonavir and aprepitant against human glioma cellsJournal of Neuro-Oncology, 2015
- Elevated SP/NK-1R in esophageal carcinoma promotes esophageal carcinoma cell proliferation and migrationGene, 2015
- Guidelines for the diagnosis and management of intrahepatic cholangiocarcinomaJournal of Hepatology, 2014
- c-Jun, at the crossroad of the signaling networkProtein & Cell, 2011